ahlam1399
09-15-2016, 07:02 PM
BRIEF-Mimedx urges FDA to reconsider draft guidances
* Mimedx says continues to believe that its marketing ofits products as section 361 hct/ps is consistent with applicablestatutes and regulationshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=eE_brhc_nwk:fkgO7NqVmT0:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=eE_brhc_nwk:fkgO7NqVmT0:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/eE_brhc_nwk
* Mimedx says continues to believe that its marketing ofits products as section 361 hct/ps is consistent with applicablestatutes and regulationshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=eE_brhc_nwk:fkgO7NqVmT0:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=eE_brhc_nwk:fkgO7NqVmT0:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=eE_brhc_nwk:fkgO7NqVmT0:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/eE_brhc_nwk